Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort

Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort

Early-stage (ES) non-small cell lung cancer (NSCLC) is diagnosed in about 30% of cases. The preferred treatment is surgery, but a significant proportion of patients experience recurrence. Neoadjuvant and adjuvant chemotherapy has a limited clinical benefit. EGFR tyrosine kinase inhibitors and immuno...

Full description

Bibliographic Details
Main Authors: Rossella Bruno, Anello Marcello Poma, Martina Panozzi, Alessandra Lenzini, Gianmarco Elia, Carmelina Cristina Zirafa, Vittorio Aprile, Marcello Carlo Ambrogi, Editta Baldini, Marco Lucchi, Franca Melfi, Antonio Chella, Andrea Sbrana, Greta Alì
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:Cancers
Subjects:
early-stage non-small cell lung cancer
targeted therapy
immunotherapy
actionable alterations
PD-L1
predictive biomarkers
Online Access:https://www.mdpi.com/2072-6694/16/7/1410

Internet

https://www.mdpi.com/2072-6694/16/7/1410

Similar Items